Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lublin
Clinical trial register · Poland

Clinical Trials in Lublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca44 Janssen Research & Development, LLC36 Hoffmann-La Roche30 Novo Nordisk A/S18 Merck Sharp & Dohme LLC16
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Lublin

523 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Active, closed
AbbVie
Phase 3
1,336
Poznan, Torun, Wroclaw, Lublin, Warsaw, Rzeszów, Chojnice, Tychy
2018-04-09
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Krakow, Lodz, Lublin, Poznan, Warsaw
2017-09-20
Active, closed
Eli Lilly and Company
Phase 3
5,637
Konin, Poznan, Wroclaw, Lublin, Warsaw, Opole, Gdansk, Gdynia
2017-07-12
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bialystok, Gdansk, Katowice, Krakow, Lodz, Lublin, Nowy Sącz, Rzeszów
2017-06-26
Active, closed
Acerta Pharma BV
Phase 3
635
Chorzów, Krakow, Lodz, Lublin, Olsztyn, Warsaw, Woj. Podkarpackie, Wroclaw
2017-04-05
Active, closed
AstraZeneca
Phase 3
987
Bialystok, Lublin, Olsztyn, Warsaw
2017-03-27
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Gdansk, Lublin, Poznan, Szczecin, Warsaw
2017-03-07
Active, closed
Acerta Pharma BV
Phase 3
310
Bialystok, Bydgoszcz, Gdansk, Krakow, Lodz, Lublin, Woj. Podkarpackie
2017-02-02
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Active, closed
Incyte Corporation
Phase 2
10
Krakow, Lublin, Warsaw
2016-11-30
Active, closed
Eisai Inc.
Phase 3
1,069
Gdansk, Lublin, Szczecin
2016-10-13
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Bialystok, Bystra, Lublin, Olsztyn, Poznan, Warsaw
2016-09-13
Active, closed
NeuroDerm Ltd.
Phase 2
214
Krakow, Lublin
2016-05-04
Active, closed
Tesaro, Inc.
Phase 1
729
Gdynia, Lublin, Olsztyn, Torun, Warsaw
2016-03-07
Active, closed
AbbVie
Phase 3
1,629
Torun, Cracow, Krakow, Wroclaw, Lublin, Grodzisk Mazowiecki, Warsaw, Bialystok
2015-12-01
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Bialystok, Bydgoszcz, Krakow, Kutno, Lodz, Lublin, Siedlce, Sochaczew
2015-11-27
Recruiting
Haukeland University Hospital
Phase 4
1,300
Lublin
2015-10
Active, closed
Acerta Pharma BV
Phase 3
535
Bydgoszcz, Gdansk, Gdynia, Krakow, Lodz, Lublin, Olsztyn, Opole
2015-06-26
Active, closed
Hoffmann-La Roche
Phase 3
154
Lublin
2015-02-02
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Wroclaw, Gdynia, Krakow, Legnica, Lodz, Lublin, Olsztyn, Warsaw
2014-11
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Lodz, Lublin, Poznan, Wroclaw
2013-07-26
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bydgoszcz, Krakow, Lublin, Poznan, Wroclaw
2013-04
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Bialystok, Gdansk, Lublin, Poznan, Rzeszów, Szczecin
2008-12-09
Rows per page Showing 501–523 of 523
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-poland/city/lublin?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 523 of those studies with a site in Lublin.

How many clinical trials are recruiting in Lublin?

243 of the 523 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 8 have not yet opened recruitment, 260 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.